El 29 de abril de 2022, Oregon Health Authority (OHA), organizó un seminario virtual vía Zoom de almuerzo y aprendizaje sobre los tratamientos contra la enfermedad de COVID-19. Se habló sobre:1. Qué tratamientos están disponibles2. Cómo conseguirlos3. Cuánto cuestan4. Y más información Hubo un grupo de expertos en COVID-19 y proveedores de salud para compartir […]

Paxlovid y Lagevrio (molnupiravir): Tratamientos contra el COVID-19 disponibles para pacientes elegibles

Disponible en inglés. Actualizado 06/22/2022: El nombre comercial de Molnupiravir es Lagevrio. Actualizaciones anteriores: Se agregó información para los sitios actuales. Se agregaron dos nuevos sitios T2T en Hood River y The Dalles. Actualmente hay 14 ubicaciones de pruebas y tratamiento en Oregón. Oregon Health Authority está trabajando para expandir el acceso al programa federal […]

COVID-19 treatments Paxlovid and Lagevrio (molnupiravir) available to eligible patients

Available in Spanish. Updated 06/23/2022: A new T2T site was added in Ontario, OR. Previous updates: Molnupiravir’s trade name is Lagevrio. Address, phone number and accessibility information was added to the existing site listings. Currently there are 14 Test to Treat locations in Oregon. Oregon Health Authority is working to expand access to the federal […]

¿Qué es el COVID prolongado? Y si lo tiene, ¿qué recursos hay disponibles?

Christine Palmer, nativa de Oregon, contrajo COVID-19 en marzo de 2020. No fue hasta julio de 2021 que le diagnosticaron COVID-19 prolongado. En estos días, incluso hablar por teléfono la agota. Antes de marzo de 2020, Christine Palmer se habría descrito a sí misma como “una de esas mamás que ves corriendo hasta detrás de […]

What is Long COVID? And if you have it, what resources are available? 

Before March 2020, Christine Palmer would have described herself as “one of those moms you see jogging behind a stroller.” The Oregon native was an outgoing, active 42-year-old with “boundless energy.” She used to bike to her education job. She rarely felt sick.  That was before she came down with COVID-19, a completely new disease at the time, with no […]

What kind of treatments exist for COVID-19?

1/25/2022: This blog has been updated to reflect new approval and authorization from the FDA for the antiviral drug remdesivir. The best way to fight COVID-19 is to avoid getting it in the first place. That means wearing a well-fitting mask, keeping gatherings small and outdoors if possible and getting vaccinated (including a booster dose if eligible.)  But the […]

New medication approved for prevention of COVID-19 in certain adults and children

On Dec. 8, 2021, the Food and Drug Administration (FDA) authorized AstraZeneca’s Evusheld under emergency use for prevention of COVID-19 infection in certain adults and children. Evusheld is a long-acting monoclonal antibody therapy.

FDA expands authorization for COVID-19 treatment to pediatric patients, including newborns

On Dec. 3, 2021, the agency expanded emergency use of bamlanivimab/etesevimab to include all patients at risk of severe disease, including newborns. “Children under one year of age who are exposed to the virus that causes COVID-19 may be at particularly high risk for severe COVID-19 and this authorization addresses the medical needs of this vulnerable population,” said Patrizia Cavazzoni, M.D., director of the FDA’s Center for Drug Evaluation and Research.